CNSP
CNSP
NASDAQ · Pharmaceuticals

Cns Pharmaceuticals Inc

$7.29
+0.19 (+2.68%)
As of May 9, 9:49 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +485.2% upside
Low Target $27.73
Average Target $42.66
High Target $55.88
Current Price $7.29
Current
$7.29
Target
$42.66
$27.73 $42.66 avg $55.88
Scenario Analysis
Bear Case
$27.73
280.4%
Low target
Base Case
$42.66
+485.2%
Avg target
Bull Case
$55.88
+666.5%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$34.80
-79.1% from high
52-Week Low
$1.90
+283.7% from low
Target vs 52W High
$42.66
+22.6% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $-5.48
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%